Research and Evaluation

2022

Binswanger, I. A., Rinehart, D., Mueller, S. R., Narwaney, K. J., Stowell, M., Wagner, N., Xu, S., Hanratty, R., Blum, J., McVaney, K., & Glanz, J. M. (2022). Naloxone Co-Dispensing with Opioids: A Cluster Randomized Pragmatic Trial. Journal of general internal medicine, 10.1007/s11606-021-07356-6
Li, X., Sullivan, P., Broz, D., Handanagic, S., & NHBS Study Group (2022). Association Between Dual Partnership and Sexual and Injecting Behaviors Among Persons Who Inject Drugs in 23 US Cities, 2018. Archives of sexual behavior, 51(5), 2667–2678.
Terasaki D. (2022). Cardiovascular medications on discharge for patients with chest pain and concurrent cocaine use. The American journal of emergency medicine, S0735-6757(22)00146-2.
Thurstone, C., Loh, R., Piatz, C., & Simpson, S. A. (2022). Adolescent Substance Use Disorder Diagnosis Correlates with Hospitalization After an Emergency Department Visit. Pediatric emergency care, 10.1097/PEC.0000000000002838.
Binswanger IA, Shetterly SM, Xu S, Narwaney KJ, McClure DL, Rinehart DJ, Nguyen AP, Glanz JM. Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment. JAMA Netw Open. 2022 Oct 3;5(10):e2234671.
Stowell, M. A., Thomas-Gale, T., Jones, H. E., Binswanger, I., & Rinehart, D. J. (2022). Perspectives among women receiving medications for opioid use disorder: Implications for development of a peer navigation intervention to improve access to family planning services. Substance abuse, 43(1), 722–732.
Choo EK, Nishijima D, Trent S, Eichelberger A, Ye Y, Audett A, Brasel K, Kazmierczak S, Cherpitel CJ. Cannabis presentations to the emergency department after MVC in the era of legalization for recreational use. J Safety Res. 2022 Feb;80:341-348.
Fischer LJ, Severtson SG, Gurrola MC, Iwanicki JL, Green JL, Dart RC. Changes in Hydrocodone Misuse Exposures Reported to U.S. Poison Centers Following Rescheduling in 2014. Subst Use Misuse. 2022;57(7):1097-1103.
Brooks KM, Castillo-Mancilla JR, Morrow M, Mawhinney S, Rowan SE, Wyles D, Blum J, Huntley R, Salah L, Tehrani A, Jimmerson LC, Roon L, Bushman LR, Anderson PL, Kiser JJ. Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use. J Antimicrob Chemother. 2022 Apr 27;77(5):1396-1403.
Black JC, Amioka E, Iwanicki JL, Dart RC, Monte AA. Evaluation of Cannabis Use Among US Adults During the COVID-19 Pandemic Within Different Legal Frameworks. JAMA Netw Open. 2022 Nov 1;5(11):e2240526.
Choo E, Trent SA, Nishijima DK, Audett A, Hendrickson RG, Eichelberger A, Brasel KJ, Ye Y, Cherpitel CJ. Increased identification of cannabis use among drivers involved in motor vehicle collisions using an expanded cannabis inventory. Acad Emerg Med. 2022 Nov;29(11):1301-1305.
Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high utilization in patients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022 Nov 22;17(1):64.
Bradley H, Austin C, Allen ST, Asher A, Bartholomew TS, Board A, Borquez A, Buchacz K, Carter A, Cooper HLF, Feinberg J,Furukawa N, Genberg B, Gorbach PM, Hagan H, Huriaux E, Hurley H, Luisi N, Martin NK, Rosenberg ES, Strathdee SA, Jarlais DCD. A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic. Int J Drug Policy. 2022 Dec;110:103889.

2021

Arifkhanova, A., McCormick Kraus, E., Al-Tayyib, A., Taub, J., Encinias, A., McEwen, D., Davidson, A., & Shlay, J. C. (2021). Estimating costs of hospitalizations associated with opioid use disorder or opioid misuse at a large, urban safety-net hospital-Denver, Colorado, 2017. Drug and alcohol dependence, 218, 108306. https://doi.org/10.1016/j.drugalcdep.2020.108306
Calcaterra, S. L., Butler, M., Olson, K., & Blum, J. (2021). The Impact of a PDMP-EHR Data Integration Combined With Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area. Journal of addiction medicine, 10.1097/ADM.0000000000000905. Advance online publication. https://doi.org/10.1097/ADM.0000000000000905
Calcaterra, S. L., Lou, Y., Everhart, R. M., Fish, L. E., & Hanratty, R. (2021). Association Between In-Clinic Opioid Administration and Discharge Opioid Prescription in Urgent Care: a Retrospective Cohort Study. Journal of general internal medicine, 36(1), 43–50. https://doi.org/10.1007/s11606-020-06059-8
Kilwein, T. M., Brown, S., Gaffaney, M., & Farrar, J. (2021). Bridging the Gap: Can Group Interventions Assist Addiction Consult Services in Providing Integrated, Comprehensive Healthcare for Patients Hospitalized for Opioid-Related Infections?. Journal of clinical psychology in medical settings, 28(2), 262–266. https://doi.org/10.1007/s10880-020-09712-w
Kinghorn, W. A., & Nussbaum, A. M. (2021). Prescribing together: A relational guide to psychopharmacology. American Psychiatric Association Publishing.
Mueller, S. R., Glanz, J. M., Nguyen, A. P., Stowell, M., Koester, S., Rinehart, D. J., & Binswanger, I. A. (2021). Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose. The International journal on drug policy, 92, 103077. https://doi.org/10.1016/j.drugpo.2020.103077
Rinehart, D. J., Stowell, M., Collings, A., Durfee, M. J., Thomas-Gale, T., Jones, H. E., & Binswanger, I. (2021). Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention. Journal of substance abuse treatment, 126, 108318. https://doi.org/10.1016/j.jsat.2021.108318
Schimmel, J., Amioka, E., Rockhill, K., Haynes, C. M., Black, J. C., Dart, R. C., & Iwanicki, J. L. (2021). Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study. Addiction (Abingdon, England), 116(1), 176–181. https://doi.org/10.1111/add.15082
Simpson, S. A., Hordes, M., Blum, J., Rinehart, D., & Al-Tayyib, A. (2021). Barriers to Engagement in Opioid Use Disorder Treatment After Buprenorphine Induction. Journal of addiction medicine, 10.1097/ADM.0000000000000943. Advance online publication. https://doi.org/10.1097/ADM.0000000000000943
Simpson, S., Shy, B., & Loh, R. (2021). More than suicide: mortality after emergency psychiatric care and implications for practice. Journal of the academy of consultation-liaison psychiatry.
Simpson, S., & Taub, J. (2021). Chapter 6: Co-occurring Substance-Use Disorder in the Emergency Department. In L. Zun, K. Nordstrom, & M. Wilson (Eds.), Behavioral Emergencies for Healthcare Providers (2nd ed., pp. 77–88). Springer International Publishing.
Toseef, M. U., Armistead, I., Bacon, E., Hawkins, E., Bender, B., Podewils, L. J., & Hurley, H. (2021). Missed appointments during COVID-19: The impact of telehealth for persons experiencing homelessness with substance use disorders. Asian journal of psychiatry, 69, 102987. Advance online publication. https://doi.org/10.1016/j.ajp.2021.102987

2020

Adams M, Sionean C, Broz D, Lewis R, Wejnert C. Serious Mental Illness Among Young People Who Inject Drugs: An Assessment of Injection Risks and Healthcare Use. J Infect Dis. 2020 Sep 2;222(Supplement_5):S401-S409. doi: 10.1093/infdis/jiaa238. PubMed PMID: 32877554.
Black JC, Margolin ZR, Olson RA, Dart RC. Online Conversation Monitoring to Understand the Opioid Epidemic: Epidemiological Surveillance Study. JMIR Public Health Surveill. 2020 Jun 29;6(2):e17073. doi: 10.2196/17073. PubMed PMID: 32597786; PubMed Central PMCID: PMC7367521.
Calcaterra SL, Klie KA. Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis. Obstet Gynecol. 2020 Apr;135(4):975. doi: 10.1097/AOG.0000000000003812. PubMed PMID: 32217961.
Cao SS, Dunham SI, Simpson SA. Prescribing Buprenorphine for Opioid Use Disorders in the ED: A Review of Best Practices, Barriers, and Future Directions. Open Access Emerg Med. 2020;12:261-274. doi: 10.2147/OAEM.S267416. eCollection 2020. Review. PubMed PMID: 33116962; PubMed Central PMCID: PMC7569244.
Dayton L, Tobin K, Falade-Nwulia O, Davey-Rothwell M, Al-Tayyib A, Saleem H, Latkin C. Racial Disparities in Overdose Prevention among People Who Inject Drugs. J Urban Health. 2020 Dec;97(6):823-830. doi: 10.1007/s11524-020-00439-5. PubMed PMID: 32514829; PubMed Central PMCID: PMC7704879.
Dean McEwen. 2020. Developing and Using an Opioid Continuum of Care Model to Improve Patient Care. NACCHO. 19(4).
Deen JT, Stone WZ, Gray CF, Prieto HA, Iams DA, Boezaart AP, Parvataneni HK. A Simple, Personalized Opioid Stratification Pathway Dramatically Reduces Opioid Utilization. Arthroplast Today. 2020 Dec;6(4):731-735. doi: 10.1016/j.artd.2020.07.005. eCollection 2020 Dec. PubMed PMID: 32923559; PubMed Central PMCID: PMC7475051.
Hurley H, Sikka M, Jenkins T, Cari EV, Thornton A. Outpatient Antimicrobial Treatment for People Who Inject Drugs. Infect Dis Clin North Am. 2020 Sep;34(3):525-538. doi: 10.1016/j.idc.2020.06.009. Review. PubMed PMID: 32782100.
Kilwein TM, Brown S, Gaffaney M, Farrar J. Bridging the Gap: Can Group Interventions Assist Addiction Consult Services in Providing Integrated, Comprehensive Healthcare for Patients Hospitalized for Opioid-Related Infections?. J Clin Psychol Med Settings. 2020 Mar 6;. doi: 10.1007/s10880-020-09712-w. [Epub ahead of print] PubMed PMID: 32144617.
Ladegard K, Thurstone C, Rylander M. Marijuana Legalization and Youth. Pediatrics. 2020 May;145(Suppl 2):S165-S174. doi: 10.1542/peds.2019-2056D. PubMed PMID: 32358207.
Lavonas EJ, Dezfulian C. Impact of the Opioid Epidemic. Crit Care Clin. 2020 Oct;36(4):753-769. doi: 10.1016/j.ccc.2020.07.006. Review. PubMed PMID: 32892827.
Lewis R, Baugher AR, Finlayson T, Wejnert C, Sionean C. Healthcare Access and Utilization Among Persons Who Inject Drugs in Medicaid Expansion and Nonexpansion States: 22 United States Cities, 2018. J Infect Dis. 2020 Sep 2;222(Supplement_5):S420-S428. doi: 10.1093/infdis/jiaa337. PubMed PMID: 32877551.
Nassau T, Al-Tayyib A, Robinson WT, Shinefeld J, Brady KA. The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015. Public Health Rep. 2020 Jul/Aug;135(1_suppl):138S-148S. doi: 10.1177/0033354920930137. PubMed PMID: 32735193; PubMed Central PMCID: PMC7407040.
Rowan SE, Kamis KF, Beum R, Bryan K, Gawenus L, Colon Sanchez D, Hurley H. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program. J Infect Dis. 2020 Sep 2;222(Supplement_5):S384-S391. doi: 10.1093/infdis/jiz694. PubMed PMID: 32877565.
Simpson S, Brooks V, DeMoss D, Lawrence R. “The Case for Fellowship Training in Emergency Psychiatry.” MedEdPublish 2020;9(1):252.
Springer SA, Barocas JA, Wurcel A, Nijhawan A, Thakarar K, Lynfield R, Hurley H, Snowden J, Thornton A, Del Rio C. Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy Agenda. J Infect Dis. 2020 Sep 2;222(Supplement_5):S230-S238. doi: 10.1093/infdis/jiz673. PubMed PMID: 32877568; PubMed Central PMCID: PMC7467230.
Wang GS, Olsen H, Severtson G, Green JL, Dart RC. The Impact of the Prescription Opioid Epidemic on Young Children: Trends and Mortality. Drug Alcohol Depend. 2020 Jun 1;211:107924. doi: 10.1016/j.drugalcdep.2020.107924. Epub 2020 Mar 13. PubMed PMID: 32178937.
Wolf C, Curry A, Nacht J, Simpson SA. Management of Alcohol Withdrawal in the Emergency Department: Current Perspectives. Open Access Emerg Med. 2020;12:53-65. doi: 10.2147/OAEM.S235288. eCollection 2020. Review. PubMed PMID: 32256131; PubMed Central PMCID: PMC7093658.
Wolf C, Rylander M, Al-Tayyib A, Simpson S. “After COVID-19 and Beyond the Opioid Wave.” Psychiatric Times 2020. Published online. [https://www.psychiatrictimes.com/view/covid-19-beyond-opioid-wave

2019

Abara WE et al. 2019. Age-related Differences in Past or Present HCV Infection among People Who Inject Drugs - National HIV Behavioral Surveillance, Eight U.S Cities, 2015. J Infect Dis. 2019 Mar 27;. doi: 10.1093/infdis/jiz142. [Epub ahead of print] PubMed PMID: 30915477.
Binswanger IA et al. 2019. Development and evaluation of a standardized research definition for opioid overdose outcomes. Subst Abus. 2019;40(1):71-79. doi: 10.1080/08897077.2018.1546263. Epub 2019 Mar 15. PubMed PMID: 30875477; PubMed Central PMCID: PMC6579660.
Black JC et al. 2019. Changes in mortality involving extended-release and long-acting opioids after implementation of a Risk Evaluation and Mitigation Strategy. Pain Med. [Epub ahead of print]
Black JC et al. 2019. Redesign of Survey of Non-Medical Use of Prescription Drugs Program improves benchmark estimates. RADARS® System Technical Report, 2019-Q1.
Donnelly JA et al. 2019. Applying National Estimates of Adults With Indications for Pre-Exposure Prophylaxis to Populations of Men Who Have Sex With Men and People Who Inject Drugs in Colorado: Modeling Study. JMIR Public Health Surveill. 2019 Jan 16;5(1):e11113. doi: 10.2196/11113. PubMed PMID: 30664481; PubMed Central PMCID: PMC6351984.
Hyer J et al. 2019. Self-Reported Alcohol, Tobacco, and Marijuana Use in Pregnant Women with Depressive Symptomatology. American Journal of Perinatology. Retrieved https://doi.org/10.1055/s-0039-1692685
Kaucher KA et al. 2019. Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program. American Journal of Emergency Medicine 2019.
Lebin JA et al. 2019. Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone. Pharmacoepidemiol Drug Saf. 2019 Jan; 28(1):25-30.
Lint M et al. 2019. Associations Between School-Based Substance Use Treatment and Academic Outcomes. Journal of Child and Adolescent Psychopharmacology.
Nelson A et al. 2019. Benzodiazepines vs barbiturates for alcohol withdrawal: Analysis of 3 different treatment protocols. American Journal of Emergency Medicine 2019.
Ng PC et al. 2019. Adolescent exposures to traditional and novel psychoactive drugs, reported to National Poison Data System (NPDS), 2007-2017. Drug Alcohol Depend. 2019 Sep 1;202:1-5.
Prieto JT et al. 2019. Monitoring opioid addiction and treatment: Do you know if your population is engaged? Drug and Alcohol Dependence 2019.
Prieto JT et al. 2019. The Detection of Opioid Misuse and Heroin Use From Paramedic Response Documentation: Machine Learning for Improved Surveillance. Journal of Medical Internet Research 2019.
Simpson SA. 2019. A Single-Session Crisis Intervention Therapy Model for Emergency Psychiatry. Clinical Practice and Cases in Emergency Medicine 3, no. 1 : 27–32.
Simpson SA. 2019. A Survey of Clinical Approaches to Suicide Risk Assessment for Patients Intoxicated on Alcohol. Psychosomatics 60, no. 2: 197–203.
Wang GS et al. 2019. Brief report: Characterization of marijuana use in US college students by state marijuana legalization status as reported to an online survey. Am J Addict. 2019 Jul; 28(4):266-269.
Wang GS et al. 2019. Novel Drugs of Abuse. Pediatr Rev. 2019 Feb;40(2):71-78.

MyChart Login

MyChart for Mobile

MyChart Sign Up

Virtual Urgent Care Now Available for Denver Health MyChart Users

Contact Us:

Donate:

Hours of Operation:

2022

2021

2020

2019

Hours of Operation:

Research and Evaluation

Substance-Related Peer-Reviewed Publications